Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?
- 1 March 2017
- journal article
- review article
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 46 (3) , 249-254
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Efficacy and safety of repeated use of ulipristal acetate in uterine fibroidsFertility and Sterility, 2015
- Prévalence du fibrome utérin en France et impact sur la qualité de vie à partir d’une enquête menée auprès de 2500 femmes de 30–55ansJournal de Gynécologie Obstétrique et Biologie de la Reproduction, 2014
- Épidémiologie du fibrome utérin en France en 2010–2012 dans les établissements de santé – Analyse des données du programme médicalisé des systèmes d’information (PMSI)Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2014
- Long-term treatment of uterine fibroids with ulipristal acetate☆Fertility and Sterility, 2014
- Ulipristal Acetate versus Placebo for Fibroid Treatment before SurgeryNew England Journal of Medicine, 2012
- Ulipristal Acetate versus Leuprolide Acetate for Uterine FibroidsNew England Journal of Medicine, 2012
- Effects of progesterone on growth factor expression in human uterine leiomyomaSteroids, 2003
- High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidenceAmerican Journal of Obstetrics and Gynecology, 2003
- Efficacy of pre‐operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic reviewBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- COMPARISON OF CELLULAR LEVELS OF STEROID RECEPTORS IN UTERINE LEIOMYOMA AND MYOMETRIUMActa Obstetricia et Gynecologica Scandinavica, 1985